31.06
Tectonic Therapeutic Inc stock is traded at $31.06, with a volume of 204.36K.
It is up +3.29% in the last 24 hours and up +34.40% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$30.07
Open:
$30.26
24h Volume:
204.36K
Relative Volume:
0.52
Market Cap:
$583.20M
Revenue:
-
Net Income/Loss:
$-74.15M
P/E Ratio:
-7.686
EPS:
-4.0411
Net Cash Flow:
$-60.29M
1W Performance:
-3.39%
1M Performance:
+34.40%
6M Performance:
+111.15%
1Y Performance:
+46.37%
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TECX
Tectonic Therapeutic Inc
|
31.06 | 564.61M | 0 | -74.15M | -60.29M | -4.0411 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
|
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Sep-03-25 | Initiated | Oppenheimer | Outperform |
| Jul-21-25 | Initiated | Truist | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-21-25 | Initiated | Mizuho | Outperform |
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
Tech Rally: Does Tectonic Therapeutic Inc stock have upside surprise potential2026 PreEarnings & Community Consensus Trade Signals - baoquankhu1.vn
Recap Report: Does Tectonic Therapeutic Inc outperform in volatile marketsMarket Trend Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Published on: 2026-03-21 15:49:43 - baoquankhu1.vn
CEO Change: Can Tectonic Therapeutic Inc outperform under higher oil prices2026 Valuation Update & Weekly High Return Stock Forecasts - baoquankhu1.vn
Aug Levels: What are analysts price targets for Tectonic Therapeutic IncQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Buybacks Report: Is Tectonic Therapeutic Inc stock forming a cup and handle2026 Technicals & Proven Capital Preservation Methods - baoquankhu1.vn
Gains Report: What are analysts price targets for Tectonic Therapeutic Inc2026 Intraday Action & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Aug Action: Does Tectonic Therapeutic Inc outperform in volatile markets2026 PostEarnings & Stepwise Trade Signal Guides - baoquankhu1.vn
Farallon Capital Management LLC Cuts Stock Position in Tectonic Therapeutic, Inc. $TECX - MarketBeat
First Light Asset Management LLC Makes New $3.18 Million Investment in Tectonic Therapeutic, Inc. $TECX - MarketBeat
Braidwell LP Makes New $11.56 Million Investment in Tectonic Therapeutic, Inc. $TECX - MarketBeat
Prosight Management LP Has $5.95 Million Stock Holdings in Tectonic Therapeutic, Inc. $TECX - MarketBeat
Gains Report: Can Tectonic Therapeutic Inc outperform under higher oil prices2026 Gainers & Long-Term Capital Growth Strategies - baoquankhu1.vn
Tectonic Therapeutic (TECX) to Release Earnings on Thursday - MarketBeat
TECX: TX45 and TX2100 advance in key indications, with pivotal data expected by early 2027 - TradingView
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Insider Sell: Marcella Ruddy Sells Shares of Tectonic Therapeuti - GuruFocus
Peter Mcnamara Sells 6,262 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 10,000 Shares of Stock - MarketBeat
Tectonic Therapeutic (TECX) CMO sells 10,000 shares in Rule 10b5-1 plan - Stock Titan
Tectonic Therapeutic (TECX) CSO sells shares after exercising options - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 9.8%Should You Sell? - MarketBeat
Stocks showing market leadership: Tectonic Therapeutic earns 96 RS rating - MSN
Published on: 2026-03-08 21:54:41 - baoquankhu1.vn
Aug Breakouts: Can Tectonic Therapeutic Inc. lead its sector in growthMarket Activity Recap & Community Driven Trade Alerts - baoquankhu1.vn
Published on: 2026-03-07 08:33:07 - baoquankhu1.vn
Unveiling Bumps: How Tectonic Therapeutic’s Recent Moves Affect the Market - timothysykes.com
[144] Tectonic Therapeutic, Inc. SEC Filing - Stock Titan
Peter Mcnamara Sells 1,650 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 1,649 Shares of Stock - MarketBeat
Tectonic Therapeutic (TECX) CEO receives option and RSU equity grants - Stock Titan
Tectonic Therapeutic (TECX) grants options and RSUs to CBO - Stock Titan
Tectonic Therapeutic (TECX) CMO receives RSU and stock option awards - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month HighHere's Why - MarketBeat
TECX SEC FilingsTectonic Therapeutic Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 11.4%What's Next? - MarketBeat
Tectonic Therapeutic to Participate in March Investor Conferences - Bitget
Quarterly Risk: Is Tectonic Therapeutic Inc stock forming a cup and handleJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - baoquankhu1.vn
TECX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Promising Biotech with a Potential 227% Upside - DirectorsTalk Interviews
Chen Yu and TCG report 6.2% stake in Tectonic Therapeutic (NASDAQ: TECX) - Stock Titan
Tectonic Therapeutics' Q4 Net Loss Widens; Phase 2 APEX Trial Data Due In 2026 - Nasdaq
Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX) and BioLife Solutions (BLFS) - The Globe and Mail
TECX: Strong cash position and advancing clinical pipeline, with key trial results expected in 2026 - TradingView
Tectonic Therapeutic, Inc. Reports Positive Phase 1b Results for TX45 in Pulmonary Hypertension and Advances TX2100 into Phase 1a Trial for Hereditary Hemorrhagic Telangiectasia - Quiver Quantitative
TECXForm 8-KCurrent report - ADVFN Ltd
Tectonic Therapeutic, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic drug cuts heart-lung pressure 29%, backed by cash into 2028 - Stock Titan
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX) - Seeking Alpha
Tectonic Therapeutic, Inc.Common Stock (NQ: TECX - The Chronicle-Journal
Tectonic Therapeutic Inc Stock (TECX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):